Apoptotic Cell Death and the Proliferative Capacity of Human Breast Cancers

The proliferative capacity (%S‐phase fraction), DNA ploidy, apoptosis frequency (DNA fragmentation) and steroid hormone receptor status (estrogen receptor, ER; progesterone receptor, PR) of 110 samples of human breast tissues with ductal invasive carcinoma were measured using biochemical and cytoflu...

Full description

Saved in:
Bibliographic Details
Main Authors: Gabriele A. Losa, Riccardo Graber
Format: Article
Language:English
Published: Wiley 1998-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/1998/906749
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566814481055744
author Gabriele A. Losa
Riccardo Graber
author_facet Gabriele A. Losa
Riccardo Graber
author_sort Gabriele A. Losa
collection DOAJ
description The proliferative capacity (%S‐phase fraction), DNA ploidy, apoptosis frequency (DNA fragmentation) and steroid hormone receptor status (estrogen receptor, ER; progesterone receptor, PR) of 110 samples of human breast tissues with ductal invasive carcinoma were measured using biochemical and cytofluorimetric procedures. The DNA fragmentation had a left‐skewed frequency distribution and an overall median value of 1.64%, whilst the median %S‐phase fraction was 8%. The median %DNA fragmentation and %S‐phase fraction were 1.96% and 16% in hyperdiploid tumours (n=29; DNA index >1.1) higher than in hypodiploid tumors (n=10; DNA index 0.96), 0.38% and 7.5%. DNA diploid tumours (n=71) had median %DNA fragmentation and %S‐phase values of 1.68% and 6%, consistently lower than the median values of DNA hyperdiploid tumours. The ER content of hypodiploid tumours was about one half (median: 5.9 fmol/mg) the median values in hyperdiploid (10.6 fmol/mg) and diploid tumours (14.6 fmol/mg). This may correlate with the lowest frequency of apoptosis in hypodiploid tumours, at least when measured by biochemical methods which only detect cells in the late phases of apoptosis. In contrast, the median PR was lowest in hyperdiploid tumours than in hypo and/or diploid tumours. The %S‐phase/%fragmented DNA ratio for the hypodiploid tumours was 19.7, significantly higher than the ratios for hyperdiploid (8.2) and diploid tumours (3.6). These findings indicated that there is an imbalance between proliferative capacity and cell death or growth arrest in human breast tumours. This imbalance may well be linked to a loss of steroid hormone control.
format Article
id doaj-art-51155740561c4fab90ac4dcf0d541aad
institution Kabale University
issn 0921-8912
1878-3651
language English
publishDate 1998-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-51155740561c4fab90ac4dcf0d541aad2025-02-03T01:03:03ZengWileyAnalytical Cellular Pathology0921-89121878-36511998-01-0116111010.1155/1998/906749Apoptotic Cell Death and the Proliferative Capacity of Human Breast CancersGabriele A. Losa0Riccardo Graber1Laboratorio di Patologia Cellulare, Istituto cantonale di Patologia, CH‐6601 Locarno, SwitzerlandLaboratorio di Patologia Cellulare, Istituto cantonale di Patologia, CH‐6601 Locarno, SwitzerlandThe proliferative capacity (%S‐phase fraction), DNA ploidy, apoptosis frequency (DNA fragmentation) and steroid hormone receptor status (estrogen receptor, ER; progesterone receptor, PR) of 110 samples of human breast tissues with ductal invasive carcinoma were measured using biochemical and cytofluorimetric procedures. The DNA fragmentation had a left‐skewed frequency distribution and an overall median value of 1.64%, whilst the median %S‐phase fraction was 8%. The median %DNA fragmentation and %S‐phase fraction were 1.96% and 16% in hyperdiploid tumours (n=29; DNA index >1.1) higher than in hypodiploid tumors (n=10; DNA index 0.96), 0.38% and 7.5%. DNA diploid tumours (n=71) had median %DNA fragmentation and %S‐phase values of 1.68% and 6%, consistently lower than the median values of DNA hyperdiploid tumours. The ER content of hypodiploid tumours was about one half (median: 5.9 fmol/mg) the median values in hyperdiploid (10.6 fmol/mg) and diploid tumours (14.6 fmol/mg). This may correlate with the lowest frequency of apoptosis in hypodiploid tumours, at least when measured by biochemical methods which only detect cells in the late phases of apoptosis. In contrast, the median PR was lowest in hyperdiploid tumours than in hypo and/or diploid tumours. The %S‐phase/%fragmented DNA ratio for the hypodiploid tumours was 19.7, significantly higher than the ratios for hyperdiploid (8.2) and diploid tumours (3.6). These findings indicated that there is an imbalance between proliferative capacity and cell death or growth arrest in human breast tumours. This imbalance may well be linked to a loss of steroid hormone control.http://dx.doi.org/10.1155/1998/906749
spellingShingle Gabriele A. Losa
Riccardo Graber
Apoptotic Cell Death and the Proliferative Capacity of Human Breast Cancers
Analytical Cellular Pathology
title Apoptotic Cell Death and the Proliferative Capacity of Human Breast Cancers
title_full Apoptotic Cell Death and the Proliferative Capacity of Human Breast Cancers
title_fullStr Apoptotic Cell Death and the Proliferative Capacity of Human Breast Cancers
title_full_unstemmed Apoptotic Cell Death and the Proliferative Capacity of Human Breast Cancers
title_short Apoptotic Cell Death and the Proliferative Capacity of Human Breast Cancers
title_sort apoptotic cell death and the proliferative capacity of human breast cancers
url http://dx.doi.org/10.1155/1998/906749
work_keys_str_mv AT gabrielealosa apoptoticcelldeathandtheproliferativecapacityofhumanbreastcancers
AT riccardograber apoptoticcelldeathandtheproliferativecapacityofhumanbreastcancers